AptarGroup, Inc. Common Stock (ATR)
120.99
-4.12 (-3.29%)
NYSE · Last Trade: May 10th, 6:00 PM EDT
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early 2026 results.
President and Chief Executive Officer Stephan Tanda told shareholders that he p
Via MarketBeat · May 9, 2026
AptarGroup (ATR) Q1 2026 Earnings Transcript
Via The Motley Fool · May 1, 2026
AptarGroup Q1 2026: Pharma Destocking Drags Earnings as Core Sales Stall for NYSE:ATRchartmill.com
Via Chartmill · April 30, 2026
Qualys delivers cloud-based security and compliance solutions to enterprise and public sector clients across multiple industries.
Via The Motley Fool · April 26, 2026
AptarGroup Inc (NYSE:ATR) Beats Q4 Revenue Estimates, Issues Cautious Q1 Outlookchartmill.com
Via Chartmill · February 5, 2026
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends to retire. The decline, which wiped out significant market capitalization in a single session, reflects investor anxiety over the
Via MarketMinute · March 11, 2026

AptarGroup delivers proprietary dispensing and sealing solutions to global healthcare, beauty, and consumer markets.
Via The Motley Fool · February 28, 2026
Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical Services (NYSE: WST). Headquartered in Exton, Pennsylvania, West is a global leader in the design and production of technologically advanced containment and delivery systems for injectable drugs. While the [...]
Via PredictStreet · December 23, 2025
Via Benzinga · September 4, 2025
Via Benzinga · July 2, 2025
Via Benzinga · June 19, 2025
Via Benzinga · June 6, 2025